Bacterial biofilm formation is a major cause of drug resistance and bacterial persistence; thus, controlling pathogenic biofilms is an important component of strategies targeting infectious bacterial diseases. Cinnamaldehyde (CNMA) has broad-spectrum antimicrobial and antibiofilm activities. In this study, we investigated the antibiofilm effects of ten CNMA derivatives and -CNMA against Gram-negative uropathogenic (UPEC) and Gram-positive . Among the CNMA analogs tested, 4-nitrocinnamaldehyde (4-nitroCNMA) showed antibacterial and antibiofilm activities against UPEC and with minimum inhibitory concentrations (MICs) for cell growth of 100 µg/mL, which were much more active than those of -CNMA. 4-NitroCNMA inhibited UPEC swimming motility, and both -CNMA and 4-nitroCNMA reduced extracellular polymeric substance production by UPEC. Furthermore, 4-nitroCNMA inhibited the formation of mixed UPEC/ biofilms. Collectively, our observations indicate that -CNMA and 4-nitroCNMA potently inhibit biofilm formation by UPEC and . We suggest efforts be made to determine the therapeutic scope of CNMA analogs, as our results suggest CNMA derivatives have potential therapeutic use for biofilm-associated diseases.
